亨迪药业
(301211)
| 流通市值：12.56亿 | | | 总市值：50.23亿 |
| 流通股本：7200.00万 | | | 总股本：2.88亿 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 1,663,102,024.22 | 1,694,326,514.68 | 1,729,396,597.93 | 1,730,192,455.29 |
| 应收票据及应收账款 | 84,992,222.6 | 67,974,778.58 | 73,391,874.6 | 94,867,322.98 |
| 其中：应收票据 | 14,672,800.43 | 15,529,961.16 | - | - |
| 应收账款 | 70,319,422.17 | 52,444,817.42 | 73,391,874.6 | 94,867,322.98 |
| 应收款项融资 | 8,217,304 | 7,102,238.49 | 27,326,142.25 | 28,076,925.4 |
| 预付款项 | 8,229,510.9 | 12,262,125.51 | 16,304,712.66 | 25,607,870.22 |
| 其他应收款合计 | 5,233,381.77 | 4,478,312.08 | 11,704,997.54 | 11,094,587.61 |
| 存货 | 167,614,148.3 | 173,804,685.14 | 132,773,557.57 | 124,563,193.56 |
| 其他流动资产 | 6,018,232.61 | 9,600,698.73 | 2,909,459.16 | 2,900,160.39 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 2,062,714,828.89 | 2,098,949,170.23 | 2,119,187,019.86 | 2,142,682,193.6 |
| 非流动资产: | | | | |
| 固定资产 | 124,027,390.86 | 127,595,996.76 | 117,865,858.44 | 119,707,779.93 |
| 在建工程 | 268,213,677.7 | 228,767,843.16 | 153,490,021.4 | 112,895,495.86 |
| 使用权资产 | 5,280,140.75 | 5,627,470.23 | 5,894,945.23 | 6,241,706.71 |
| 无形资产 | 70,577,101.92 | 71,071,135.94 | 71,603,985.59 | 72,160,835.24 |
| 长期待摊费用 | 1,261,812.25 | 1,333,235.59 | 1,699,652.49 | 1,159,626.48 |
| 递延所得税资产 | 2,194,552.13 | 2,194,552.13 | 1,278,986.23 | 1,278,986.23 |
| 其他非流动资产 | 7,994,759.13 | 11,031,571.75 | 27,862,701.15 | 36,381,305.61 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 479,549,434.74 | 447,621,805.56 | 379,696,150.53 | 349,825,736.06 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 2,542,264,263.63 | 2,546,570,975.79 | 2,498,883,170.39 | 2,492,507,929.66 |
| 流动负债: | | | | |
| 应付票据及应付账款 | 91,731,980.19 | 117,705,826.1 | 87,924,334.88 | 95,160,545.33 |
| 其中：应付票据 | 7,900,000 | 7,900,000 | 17,000,000 | 17,000,000 |
| 应付账款 | 83,831,980.19 | 109,805,826.1 | 70,924,334.88 | 78,160,545.33 |
| 合同负债 | 10,423,080.89 | 15,005,907.81 | 12,692,792.18 | 17,190,824.78 |
| 应付职工薪酬 | 7,242,397.28 | 10,872,019.72 | 7,215,571.56 | 6,719,555.58 |
| 应交税费 | 9,755,777.54 | 15,918,206.37 | 21,226,348.76 | 23,091,354.52 |
| 其他应付款合计 | 3,996,538.77 | 3,026,094.76 | 14,680,091.26 | 22,223,857.32 |
| 一年内到期的非流动负债 | 1,508,198.7 | 1,508,198.7 | 506,434.79 | 702,889.99 |
| 其他流动负债 | 8,682,421.35 | 11,105,102.09 | 15,628,909.9 | 20,577,134.84 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 133,340,394.72 | 175,141,355.55 | 159,874,483.33 | 185,666,162.36 |
| 非流动负债: | | | | |
| 租赁负债 | 4,407,294.29 | 5,154,973.12 | 6,430,864.6 | 6,430,864.6 |
| 递延收益 | 2,088,629.46 | 2,097,742.68 | 195,031.04 | 204,144.26 |
| 递延所得税负债 | 7,492,063.02 | 7,492,063.02 | 5,659,328.49 | 5,659,328.49 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 13,987,986.77 | 14,744,778.82 | 12,285,224.13 | 12,294,337.35 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 147,328,381.49 | 189,886,134.37 | 172,159,707.46 | 197,960,499.71 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 288,000,000 | 288,000,000 | 288,000,000 | 288,000,000 |
| 资本公积 | 1,756,512,267.22 | 1,756,512,267.22 | 1,756,512,267.22 | 1,756,512,267.22 |
| 专项储备 | 869,443.52 | - | 1,709,031.28 | 1,009,108.91 |
| 盈余公积 | 49,972,124.59 | 49,972,124.59 | 33,549,551.58 | 33,549,551.58 |
| 未分配利润 | 299,582,046.81 | 262,200,449.61 | 246,952,612.85 | 215,476,502.24 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 2,394,935,882.14 | 2,356,684,841.42 | 2,326,723,462.93 | 2,294,547,429.95 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 2,394,935,882.14 | 2,356,684,841.42 | 2,326,723,462.93 | 2,294,547,429.95 |
| 负债和股东权益合计 | 2,542,264,263.63 | 2,546,570,975.79 | 2,498,883,170.39 | 2,492,507,929.66 |
| 公告日期 | 2024-04-29 | 2024-04-23 | 2023-10-18 | 2023-08-25 |
| 审计意见(境内) | | 标准无保留意见 | | |